The role of IL12 in toxoplasmosis
Open Access
- 31 October 1995
- journal article
- review article
- Published by Elsevier in Research in Immunology
- Vol. 146 (7-8) , 546-552
- https://doi.org/10.1016/0923-2494(96)83030-6
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Transforming growth factor‐β inhibits interleukin‐12‐induced production of interferon‐γ by natural killer cells: A role for transforming growth factor‐β in the regulation of T cell‐independent resistance to Toxoplasma gondiiEuropean Journal of Immunology, 1995
- Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor alpha production.The Journal of Experimental Medicine, 1995
- The role of cytokines in toxoplasmosisBiotherapy, 1994
- Possible role of nitric oxide in malarial immunosuppressionParasite Immunology, 1994
- Toxoplasmosis in Patients with CancerClinical Infectious Diseases, 1993
- Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.The Journal of Experimental Medicine, 1993
- The role of natural killer cells in innate resistance to infectionCurrent Opinion in Immunology, 1993
- Interleukin 1: an important mediator of host resistance against Pneumocystis carinii.The Journal of Experimental Medicine, 1992
- Low dosages of interleukin 1 protect mice against lethal cerebral malaria.The Journal of Experimental Medicine, 1990
- Inhibition of cytokine production by cyclosporin A and transforming growth factor beta.The Journal of Experimental Medicine, 1987